{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:14:39Z","timestamp":1793621679113,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274531"],"award-info":[{"award-number":["82274531"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yueyang Hospital\u2019s \u201cRevealing the Leader\u201d Translational Medicine Research Fund in 2024","award":["2024YJJB09"],"award-info":[{"award-number":["2024YJJB09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05177-2","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T09:54:09Z","timestamp":1763805249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["QuYuShengXin formula reshapes bile-acid-mediated macrophage polarization in the treatment of ulcerative colitis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiachun","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"5177_CR1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402:571\u201384.","journal-title":"Lancet"},{"key":"5177_CR2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2023.15389","volume":"330","author":"B Gros","year":"2023","unstructured":"Gros B, Kaplan GG. Ulcerative colitis in adults: A review. JAMA. 2023;330:951\u201365.","journal-title":"JAMA"},{"key":"5177_CR3","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.3748\/wjg.v25.i47.6866","volume":"25","author":"S Selvaratnam","year":"2019","unstructured":"Selvaratnam S, Gullino S, Shim L, Lee E, Lee A, Paramsothy S, et al. Epidemiology of inflammatory bowel disease in South america: A systematic review. World J Gastroenterol. 2019;25:6866\u201375.","journal-title":"World J Gastroenterol"},{"key":"5177_CR4","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s12325-023-02473-6","volume":"40","author":"M Barreiro-de Acosta","year":"2023","unstructured":"Barreiro-de Acosta M, Molero A, Artime E, D\u00edaz-Cerezo S, Liz\u00e1n L, de Paz HD, et al. Epidemiological, Clinical, Patient-Reported and economic burden of inflammatory bowel disease (Ulcerative colitis and crohn\u2019s disease) in spain: A systematic review. Adv Ther. 2023;40:1975\u20132014.","journal-title":"Adv Ther"},{"key":"5177_CR5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/inthealth\/ihaa005","volume":"12","author":"P Hodges","year":"2020","unstructured":"Hodges P, Kelly P. Inflammatory bowel disease in africa: what is the current state of knowledge? Int Health. 2020;12:222\u201330.","journal-title":"Int Health"},{"key":"5177_CR6","first-page":"1839","volume":"19","author":"J Zhao","year":"2013","unstructured":"Zhao J, Ng SC, Lei Y, Yi F, Li J, Yu L, et al. First prospective, population-based inflammatory bowel disease incidence study in Mainland of china: the emergence of Western disease. Inflamm Bowel Dis. 2013;19:1839\u201345.","journal-title":"Inflamm Bowel Dis"},{"key":"5177_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00384-023-04417-6","volume":"38","author":"M Yamazaki","year":"2023","unstructured":"Yamazaki M, Chung H, Xu Y, Qiu H. Trends in the prevalence and incidence of ulcerative colitis in Japan and the US. Int J Colorectal Dis. 2023;38:135.","journal-title":"Int J Colorectal Dis"},{"key":"5177_CR8","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3748\/wjg.v30.i9.1154","volume":"30","author":"S Kim","year":"2024","unstructured":"Kim S, Lee HJ, Lee SW, Park S, Koh SJ, Im JP, et al. Recent trends in the epidemiology and clinical outcomes of inflammatory bowel disease in South Korea, 2010\u20132018. World J Gastroenterol. 2024;30:1154\u201363.","journal-title":"World J Gastroenterol"},{"key":"5177_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ibd\/izz104","volume":"26","author":"KT Park","year":"2020","unstructured":"Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, et al. The cost of inflammatory bowel disease: an initiative from the crohn\u2019s & colitis foundation. Inflamm Bowel Dis. 2020;26:1\u201310.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"5177_CR10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.cgh.2019.07.022","volume":"18","author":"GR Lichtenstein","year":"2020","unstructured":"Lichtenstein GR, Shahabi A, Seabury SA, et al. Lifetime economic burden of crohn\u2019s disease and ulcerative colitis by age at diagnosis. Clin Gastroenterol Hepatol. 2020;18(4):889\u2013e89710.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5177_CR11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40273-017-0601-6","volume":"36","author":"E Stawowczyk","year":"2018","unstructured":"Stawowczyk E, Kawalec P. A systematic review of the Cost-Effectiveness of biologics for ulcerative colitis. PharmacoEconomics. 2018;36:419\u201334.","journal-title":"PharmacoEconomics"},{"key":"5177_CR12","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(08)61354-9","volume":"372","author":"JL Tang","year":"2008","unstructured":"Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet. 2008;372:1938\u201340.","journal-title":"Lancet"},{"key":"5177_CR13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3736\/jintegrmed2013022","volume":"11","author":"SA Nirmal","year":"2013","unstructured":"Nirmal SA, Ingale JM, Pattan SR, Bhawar SB. Amaranthus Roxburghianus root extract in combination with Piperine as a potential treatment of ulcerative colitis in mice. J Integr Med. 2013;11:206\u201312.","journal-title":"J Integr Med"},{"key":"5177_CR14","first-page":"105","volume":"26","author":"JX Li","year":"2018","unstructured":"Li JX, Chen J. Consensus opinion on the diagnosis and treatment of ulcerative colitis with integrated traditional Chinese and Western medicine. Chin J Integr Trad West Med Dig(Chin). 2018;26:105\u201311. https:\/\/www.cnki.com.cn\/Article\/CJFDTOTAL-ZXPW201802001.htm.","journal-title":"Chin J Integr Trad West Med Dig(Chin)"},{"key":"5177_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2095-4964(14)60011-X","volume":"12","author":"A Rashidian","year":"2014","unstructured":"Rashidian A, Mehrzadi S, Ghannadi AR, Mahzooni P, Sadr S, Minaiyan M. Protective effect of ginger volatile oil against acetic acid-induced colitis in rats: a light microscopic evaluation. J Integr Med. 2014;12:115\u201320.","journal-title":"J Integr Med"},{"key":"5177_CR16","first-page":"54","volume":"51","author":"D Gan","year":"2017","unstructured":"Gan D, Han CP, Feng Z, Jin W, Yang HJ, Li Y, et al. Clinical research of Quyu Shengxin formula combined with mesalazine in treating mild to moderate ulcerative colitis. SH J TCM(Chin). 2017;51:54\u20137. https:\/\/www.cnki.com.cn\/Article\/CJFDTOTAL-SHZZ201708016.htm.","journal-title":"SH J TCM(Chin)"},{"key":"5177_CR17","doi-asserted-by":"crossref","unstructured":"Wu C, Yang H, Han C, Wang Q, Zhang H, Huang T, et al. Quyu Shengxin Decoction Alleviates DSS-Induced Ulcerative Colitis in Mice by Suppressing RIP1\/RIP3\/NLRP3 Signalling. Evid Based Complement Alternat Med. 2021;2021:6682233.","DOI":"10.1155\/2021\/6682233"},{"key":"5177_CR18","volume":"2019","author":"H Yang","year":"2019","unstructured":"Yang H, Li Y, Shen S, Gan D, Han C, Wu J, et al. Network pharmacology-based investigation into the mechanisms of quyushengxin formula for the treatment of ulcerative colitis. Evid Based Complement Alternat Med. 2019;2019:7870424.","journal-title":"Evid Based Complement Alternat Med"},{"key":"5177_CR19","unstructured":"Lu YC, Wang ZY, Yang HJ, Han CP, Zhou HL, Li Y, et al. Effect of Decoction for dispeling stasis and generating new tissue on fecal bile acid metabolism in mice with mild to moderate ulcerative colitis. Mod J Integr Traditional Chin Western Med. 2024;33(4). https:\/\/www.cnki.com.cn\/Article\/CJFDTOTAL-XDJH202404007.htm."},{"key":"5177_CR20","doi-asserted-by":"crossref","first-page":"999179","DOI":"10.3389\/fphar.2022.999179","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang Z, Lin S, Feng W, Liu Y, Song Z, Pan G, et al. A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: macrophage polarization. Front Pharmacol. 2022;13:999179.","journal-title":"Front Pharmacol"},{"key":"5177_CR21","doi-asserted-by":"crossref","first-page":"G59","DOI":"10.1152\/ajpgi.00123.2016","volume":"311","author":"RA Isidro","year":"2016","unstructured":"Isidro RA, Appleyard CB. Colonic macrophage polarization in homeostasis, inflammation, and cancer. Am J Physiol Gastrointest Liver Physiol. 2016;311:G59\u201373.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5177_CR22","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233:6425\u201340.","journal-title":"J Cell Physiol"},{"key":"5177_CR23","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1097\/MIB.0000000000000824","volume":"22","author":"ST Gren","year":"2016","unstructured":"Gren ST, Grip O. Role of monocytes and intestinal macrophages in Crohn\u2019s disease and ulcerative colitis. Inflamm Bowel Dis. 2016;22:1992\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"5177_CR24","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/ibd\/izaa342","volume":"27","author":"N Li","year":"2021","unstructured":"Li N, Zhan S, Tian Z, Liu C, Xie Z, Zhang S, et al. Alterations in bile acid metabolism associated with inflammatory bowel disease. Inflamm Bowel Dis. 2021;27:1525\u201340.","journal-title":"Inflamm Bowel Dis"},{"key":"5177_CR25","first-page":"266","volume":"31","author":"E Tiratterra","year":"2018","unstructured":"Tiratterra E, Franco P, Porru E, Katsanos KH, Christodoulou DK, Roda G. Role of bile acids in inflammatory bowel disease. Ann Gastroenterol. 2018;31:266\u201372.","journal-title":"Ann Gastroenterol"},{"key":"5177_CR26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","volume":"27","author":"SR Sinha","year":"2020","unstructured":"Sinha SR, Haileselassie Y, Nguyen LP, Tropini C, Wang M, Becker LS, et al. Dysbiosis-Induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020;27:659\u201370.","journal-title":"Cell Host Microbe"},{"key":"5177_CR27","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3748\/wjg.v27.i24.3609","volume":"27","author":"ZH Yang","year":"2021","unstructured":"Yang ZH, Liu F, Zhu XR, Suo FY, Jia ZJ, Yao SK. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World J Gastroenterol. 2021;27:3609\u201329.","journal-title":"World J Gastroenterol"},{"key":"5177_CR28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","volume":"62","author":"H Duboc","year":"2013","unstructured":"Duboc H, Rajca S, Rainteau D, Benarous D, Maubert MA, Quervain E, Thomas G, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2013;62:531\u20139.","journal-title":"Gut"},{"key":"5177_CR29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/imm.12045","volume":"139","author":"K Yoneno","year":"2013","unstructured":"Yoneno K, Hisamatsu T, Shimamura K, Kamada N, Ichikawa R, Kitazume MT, et al. TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn\u2019s disease. Immunology. 2013;139:19\u201329.","journal-title":"Immunology"},{"key":"5177_CR30","doi-asserted-by":"crossref","first-page":"e0176715","DOI":"10.1371\/journal.pone.0176715","volume":"12","author":"TWH Pols","year":"2017","unstructured":"Pols TWH, Puchner T, Korkmaz HI, Vos M, Soeters MR, de Vries CJM. Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the vitamin D receptor. PLoS One. 2017;12:e0176715.","journal-title":"PLoS One"},{"key":"5177_CR31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12016-014-8443-x","volume":"48","author":"V Keitel","year":"2015","unstructured":"Keitel V, Reich M, H\u00e4ussinger D. TGR5: pathogenetic role and\/or therapeutic target in fibrosing cholangitis? Clin Rev Allergy Immunol. 2015;48:218\u201325.","journal-title":"Clin Rev Allergy Immunol"},{"key":"5177_CR32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.tips.2015.08.002","volume":"36","author":"A Perino","year":"2015","unstructured":"Perino A, Schoonjans K. TGR5 and immunometabolism: insights from physiology and pharmacology. Trends Pharmacol Sci. 2015;36:847\u201357.","journal-title":"Trends Pharmacol Sci"},{"key":"5177_CR33","first-page":"646","volume":"7","author":"C Guo","year":"2016","unstructured":"Guo C, Chen WD, Wang YD. TGR5, not only a metabolic regulator. Front Physiol. 2016;7:646.","journal-title":"Front Physiol"},{"key":"5177_CR34","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1681\/ASN.2014121271","volume":"27","author":"XX Wang","year":"2016","unstructured":"Wang XX, Edelstein MH, Gafter U, Qiu L, Luo Y, Dobrinskikh E, et al. G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes. J Am Soc Nephrol. 2016;27:1362\u201378.","journal-title":"J Am Soc Nephrol"},{"key":"5177_CR35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090.","journal-title":"Eur J Pharmacol"},{"key":"5177_CR36","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood-2008-12-172825","volume":"113","author":"T Hagemann","year":"2009","unstructured":"Hagemann T, Biswas SK, Lawrence T, Sica A, Lewis CE. Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. Blood. 2009;113:3139\u201346.","journal-title":"Blood"},{"key":"5177_CR37","volume":"35","author":"A Ray","year":"2010","unstructured":"Ray A, Dittel BN. Isolation of mouse peritoneal cavity cells. J Vis Exp. 2010;35:1488.","journal-title":"J Vis Exp"},{"key":"5177_CR38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cgh.2017.06.016","volume":"16","author":"M Fumery","year":"2018","unstructured":"Fumery M, Singh S, Dulai PS, Gower-Rousseau C, Peyrin-Biroulet L, Sandborn WJ. Natural history of adult ulcerative colitis in population-based cohorts: a systematic review. Clin Gastroenterol Hepatol. 2018;16:343\u201356.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5177_CR39","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","volume":"49","author":"L Du","year":"2020","unstructured":"Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020;49:643\u201354.","journal-title":"Gastroenterol Clin North Am"},{"key":"5177_CR40","doi-asserted-by":"crossref","first-page":"900251","DOI":"10.3389\/fmed.2022.900251","volume":"25","author":"H Yang","year":"2022","unstructured":"Yang H, Zhou R, Bai X, Guo M, Ruan G, Wang L, et al. Trend and geographic variation in incidence and prevalence of inflammatory bowel disease in regions across china: A nationwide employee study between 2013 and 2016. Front Med (Lausanne). 2022;25:900251.","journal-title":"Front Med (Lausanne)"},{"key":"5177_CR41","first-page":"e44895","volume":"15","author":"K Alnafisah","year":"2023","unstructured":"Alnafisah K, Alsaleem HN, Aldakheel FN, Alrashidi AB, Alayid RA, Almuhayzi HN, et al. Anxiety and depression in patients with inflammatory bowel disease at King Fahad specialist Hospital, Qassim region. Cureus. 2023;15:e44895.","journal-title":"Cureus"},{"key":"5177_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111580","volume":"139","author":"H Shen","year":"2021","unstructured":"Shen H, Zhang S, Zhao W, Ren S, Ke X, Gu Q, et al. Randomised clinical trial: efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis. Biomed Pharmacother. 2021;139:111580.","journal-title":"Biomed Pharmacother"},{"key":"5177_CR43","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jep.2011.08.057","volume":"141","author":"Y Gong","year":"2012","unstructured":"Gong Y, Zha Q, Li L, Liu Y, Yang B, Liu L, et al. Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study. J Ethnopharmacol. 2012;141:592\u20138.","journal-title":"J Ethnopharmacol"},{"key":"5177_CR44","first-page":"99","volume":"21","author":"D Gan","year":"2019","unstructured":"Gan D, Wang ZY. Research on clinical and intestinal flora effects of 2 Kuijie formula in treating mild-to-moderate ulcerative colitis. J Liaoning Univ TCM(Chin). 2019;21:99\u2013103. https:\/\/www.cnki.com.cn\/Article\/CJFDTOTAL-LZXB201912030.htm.","journal-title":"J Liaoning Univ TCM(Chin)"},{"key":"5177_CR45","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1080\/00365520701409035","volume":"42","author":"T Olsen","year":"2007","unstructured":"Olsen T, Goll R, Cui G, Husebekk A, Vonen B, Birketvedt GS, et al. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis. Scand J Gastroenterol. 2007;42:1312\u201320.","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl 1","key":"5177_CR46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/11586290-000000000-00000","volume":"24","author":"F Magro","year":"2010","unstructured":"Magro F, Portela F. Management of inflammatory bowel disease with Infliximab and other anti-tumor necrosis factor alpha therapies. BioDrugs. 2010;24(Suppl 1):3\u201314.","journal-title":"BioDrugs"},{"key":"5177_CR47","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/eji.201141550","volume":"41","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA. A clinical perspective of IL-1\u03b2 as the gatekeeper of inflammation. Eur J Immunol. 2011;41:1203\u201317.","journal-title":"Eur J Immunol"},{"key":"5177_CR48","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1100\/2011\/212680","volume":"11","author":"M Sahoo","year":"2011","unstructured":"Sahoo M, Ceballos-Olvera I, del Barrio L, Re F. Role of the inflammasome, IL-1\u03b2, and IL-18 in bacterial infections. ScientificWorldJournal. 2011;11:2037\u201350.","journal-title":"ScientificWorldJournal"},{"issue":"10","key":"5177_CR49","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nri2851","volume":"10","author":"TD Kanneganti","year":"2010","unstructured":"Kanneganti TD. Central roles of NLRs and inflammasomes in viral infection. Nat Rev Immunol. 2010;10(10):688\u201398. https:\/\/doi.org\/10.1038\/nri2851.","journal-title":"Nat Rev Immunol"},{"key":"5177_CR50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2567.2010.03283.x","volume":"130","author":"G Guarda","year":"2010","unstructured":"Guarda G, So A. Regulation of inflammasome activity. Immunology. 2010;130:329\u201336.","journal-title":"Immunology"},{"key":"5177_CR51","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s10753-021-01449-4","volume":"44","author":"Q Yin","year":"2021","unstructured":"Yin Q, Pi X, Jiang Y, Ren G, Liu Z, Liu H. An immuno-blocking agent targeting IL-1\u03b2 and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice. Inflammation. 2021;44:1724\u201336.","journal-title":"Inflammation"},{"key":"5177_CR52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1124\/jpet.104.068023","volume":"311","author":"W Cao","year":"2004","unstructured":"Cao W, Vrees MD, Potenti FM, Harnett KM, Fiocchi C, Pricolo VE. Interleukin 1beta-induced production of H2O2 contributes to reduced sigmoid colonic circular smooth muscle contractility in ulcerative colitis. J Pharmacol Exp Ther. 2004;311:60\u201370.","journal-title":"J Pharmacol Exp Ther"},{"key":"5177_CR53","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4049\/jimmunol.140.2.508","volume":"140","author":"Y Takai","year":"1988","unstructured":"Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol. 1988;140:508\u201312.","journal-title":"J Immunol"},{"key":"5177_CR54","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1084\/jem.167.2.332","volume":"167","author":"A Muraguchi","year":"1988","unstructured":"Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, et al. The essential role of B cell stimulatory factor 2 (BSF-2\/IL-6) for the terminal differentiation of B cells. J Exp Med. 1988;167:332\u201344.","journal-title":"J Exp Med"},{"key":"5177_CR55","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1084\/jem.167.4.1417","volume":"167","author":"C Uyttenhove","year":"1988","unstructured":"Uyttenhove C, Coulie PG, Van Snick J. T cell growth and differentiation induced by interleukin-HP1\/IL-6, the murine hybridoma\/plasmacytoma growth factor. J Exp Med. 1988;167:1417\u201327.","journal-title":"J Exp Med"},{"key":"5177_CR56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gut.35.1.77","volume":"35","author":"MZ Mazlam","year":"1994","unstructured":"Mazlam MZ, Hodgson HJ. Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease. Gut. 1994;35:77\u201383.","journal-title":"Gut"},{"key":"5177_CR57","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/ibd.20148","volume":"13","author":"J Mudter","year":"2007","unstructured":"Mudter J, Neurath MF. Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis. 2007;13:1016\u201323.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"5177_CR58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12944-023-01971-4","volume":"22","author":"S Sommersberger","year":"2023","unstructured":"Sommersberger S, Gunawan S, Elger T, Fererberger T, Loibl J, Huss M, et al. Altered fecal bile acid composition in active ulcerative colitis. Lipids Health Dis. 2023;22(1):199.","journal-title":"Lipids Health Dis"},{"key":"5177_CR59","volume":"21","author":"L Liu","year":"2020","unstructured":"Liu L, Guo H, Song A, Huang J, Zhang Y, Jin S, et al. Progranulin inhibits LPS-induced macrophage M1 polarization via NF-\u03baB and MAPK pathways. BMC Immunol. 2020;21:32.","journal-title":"BMC Immunol"},{"key":"5177_CR60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/prd.12032","volume":"63","author":"C Sima","year":"2013","unstructured":"Sima C, Glogauer M. Macrophage subsets and osteoimmunology: tuning of the immunological recognition and effector systems that maintain alveolar bone. Periodontol 2000. 2013;63:80\u2013101.","journal-title":"Periodontol 2000"},{"key":"5177_CR61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cellimm.2014.03.012","volume":"291","author":"CC Bain","year":"2014","unstructured":"Bain CC, Mowat AM. The monocyte-macrophage axis in the intestine. Cell Immunol. 2014;291:41\u20138.","journal-title":"Cell Immunol"},{"key":"5177_CR62","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/ibd\/izab029","volume":"27","author":"S Dharmasiri","year":"2021","unstructured":"Dharmasiri S, Garrido-Martin EM, Harris RJ, Bateman AC, Collins JE, Cummings JRF, et al. Human intestinal macrophages are involved in the pathology of both ulcerative colitis and Crohn disease. Inflamm Bowel Dis. 2021;27:1641\u201352.","journal-title":"Inflamm Bowel Dis"},{"key":"5177_CR63","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.immuni.2014.03.011","volume":"40","author":"DS Shouval","year":"2014","unstructured":"Shouval DS, Biswas A, Goettel JA, McCann K, Conaway E, Redhu NS, et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity. 2014;40:706\u201319.","journal-title":"Immunity"},{"key":"5177_CR64","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1084\/jem.20091233","volume":"206","author":"AM Smith","year":"2009","unstructured":"Smith AM, Rahman FZ, Hayee B, Graham SJ, Marks DJ, Sewell GW, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn\u2019s disease. J Exp Med. 2009;206:1883\u201397.","journal-title":"J Exp Med"},{"key":"5177_CR65","first-page":"1122","volume":"12","author":"FM Bloemendaal","year":"2018","unstructured":"Bloemendaal FM, Koelink PJ, van Schie KA, Rispens T, Peters CP, Buskens CJ, et al. TNF-anti-TNF immune complexes inhibit IL-12\/IL-23 secretion by inflammatory macrophages via an Fc-dependent mechanism. J Crohns Colitis. 2018;12:1122\u201330.","journal-title":"J Crohns Colitis"},{"key":"5177_CR66","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/cei.12375","volume":"177","author":"N Nazareth","year":"2014","unstructured":"Nazareth N, Magro F, Silva J, Duro M, Gracio D, Coelho R, et al. Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection. Clin Exp Immunol. 2014;177:703\u201311.","journal-title":"Clin Exp Immunol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05177-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05177-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05177-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T19:03:33Z","timestamp":1767467013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-025-05177-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5177"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05177-2","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The entire study was approved by the Laboratory Animal Ethics Committee of Yueyang Hospital of Integrated Traditional Chinese Medicine(No. YYLAC-2023-215).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}